Oral Supplements for Eczema
Based on the highest quality guideline evidence, oral supplements are generally NOT recommended for treating established atopic dermatitis, as most lack adequate data to support their use. 1
Evidence-Based Recommendations from Guidelines
Supplements NOT Recommended (Strong Evidence Against)
The 2014 American Academy of Dermatology guidelines systematically reviewed dietary supplements and found:
Evening Primrose Oil & Borage Oil: Multiple RCTs showed no benefit compared to placebo 1. A comprehensive Cochrane review of 27 studies (1,596 participants) confirmed these oils fail to improve eczema symptoms 2.
Fish Oil (Omega-3 fatty acids): Little supportive data despite theoretical anti-inflammatory properties 1.
Probiotics/Prebiotics: Limited evidence for treating established AD; not recommended 1.
Zinc: Not helpful in RCTs 1.
Vitamin B6 (Pyridoxine): No difference in one 4-week placebo-controlled study 1.
Multivitamins: Have not been adequately tested 1.
Supplements with Insufficient Evidence (Conditional Against)
- Vitamin D & E: Some studies suggest mild positive effects, but the guidelines explicitly state "larger, well-controlled trials are warranted prior to any formal recommendations" 1. While one small 2011 study showed SCORAD reductions of 35-64% with vitamins D and E 3, this single study is insufficient to override guideline recommendations.
Emerging Research (Not Yet Guideline-Supported)
L-Histidine (Most Promising)
The most recent high-quality research shows:
- Adults: 4g daily reduced AD severity by 34% at 4 weeks (P<0.003) 4
- Children (mean age 3.5y): 0.8g daily reduced severity by 49% at 12 weeks (P<0.02) 4
- Well-tolerated with no causally-related adverse events
- However, this is not yet incorporated into clinical guidelines
Clinical Algorithm
For patients asking about supplements:
First-line approach: Optimize topical therapy (corticosteroids, calcineurin inhibitors) and basic skin care 5
If inadequate control: Consider phototherapy or systemic agents (dupilumab is first-line systemic) 5, NOT supplements
Avoid routine supplementation: Do not recommend evening primrose oil, borage oil, fish oil, probiotics, or zinc based on current evidence 1
Vitamin D/E consideration: Only if deficiency is documented through testing; supplementation for AD treatment alone is not supported
L-Histidine: May discuss as investigational option in motivated patients, but emphasize lack of guideline support
Critical Pitfalls to Avoid
- Do not recommend elimination diets based solely on allergy testing without documented, clinically relevant food allergies 1
- Avoid excessively restrictive diets in children—these have caused weight loss, poor growth, calcium deficiency, and hypovitaminosis 1
- Do not delay effective treatments (topical or systemic therapies) in favor of unproven supplements
- Remember: Even with documented food allergies, avoidance diets are unlikely to affect the course of AD 1
The Bottom Line
The 2024 AAD guidelines for systemic therapy make no mention of oral supplements as treatment options 5, reinforcing that evidence-based management focuses on topical therapies, phototherapy, and FDA-approved systemic agents like dupilumab. While L-Histidine shows promise in recent research 4, it has not been validated in guidelines and should not replace proven therapies.